Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ibex Technologies's share price for the quarter that ended in Jan. 2024 was €0.76. Ibex Technologies's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 24.51 Mil. Therefore, Ibex Technologies's market cap for the quarter that ended in Jan. 2024 was €18.63 Mil.
Ibex Technologies's quarterly market cap
declined
from Jul. 2023 (€17.45 Mil) to Oct. 2023 (€13.55 Mil) but then
increased
from Oct. 2023 (€13.55 Mil) to Jan. 2024 (€18.63 Mil).
Ibex Technologies's annual market cap
increased
from Jul. 2021 (€4.82 Mil) to Jul. 2022 (€7.19 Mil) and
increased
from Jul. 2022 (€7.19 Mil) to Jul. 2023 (€17.45 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ibex Technologies's Enterprise Value for Today is €18.69 Mil.
Ibex Technologies Market Cap Historical Data
The historical data trend for Ibex Technologies's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ibex Technologies's Market Cap
For the Biotechnology subindustry, Ibex Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibex Technologies's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ibex Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where Ibex Technologies's Market Cap falls into.
Ibex Technologies Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ibex Technologies's Market Cap for the fiscal year that ended in Jul. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ibex Technologies (STU:IBT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ibex Technologies Market Cap Related Terms
Thank you for viewing the detailed overview of Ibex Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:IBT has been successfully added to your 